Dopaminergic psychosis in advanced Parkinson's disease

Adv Neurol. 1990;53:391-7.
No abstract available

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Aged
  • Antiparkinson Agents / administration & dosage
  • Antiparkinson Agents / adverse effects*
  • Drug Therapy, Combination
  • Humans
  • Long-Term Care
  • Longitudinal Studies
  • Parkinson Disease / drug therapy*
  • Psychoses, Substance-Induced / etiology*
  • Receptors, Dopamine / drug effects*
  • Risk Factors

Substances

  • Antiparkinson Agents
  • Receptors, Dopamine